UBS Maintains a 'Neutral' on VeriFone (PAY); Key Is Execution Because Expectations Remain High
Tweet
Share
E-mailGet Alerts PAY Hot Sheet
Price: $20.10 -2.52%
Rating Summary:
3 Buy, 29 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
3 Buy, 29 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
UBS maintains a 'Neutral' on VeriFone (NYSE: PAY) price target raised $1 to $51.
UBS analyst said, "PAY posted 1Q12 revs. of $420 mn (UBSe: $418 mn) and an EPS beat ($0.58 vs. UBSe/consensus $0.52) on services-driven higher gross margins and strong int’l growth. Our FY12-13-14 EPS estimates are now $2.65 (+$0.07), $3.24 (+$0.01), and $3.72 (+$0.01), on 1Q results and guidance."
"While PAY is better positioned now than a year ago, acquisitions have turned it from a simpler organic growth story into a more complicated creature. PAY benefits from secular trends, but is now more opaque given integration costs/risks, one-time items, and additional debt..."
For an analyst ratings summary and ratings history on VeriFone click here. For more ratings news on VeriFone click here.
Shares of VeriFone closed at $46.55 yesterday.
UBS analyst said, "PAY posted 1Q12 revs. of $420 mn (UBSe: $418 mn) and an EPS beat ($0.58 vs. UBSe/consensus $0.52) on services-driven higher gross margins and strong int’l growth. Our FY12-13-14 EPS estimates are now $2.65 (+$0.07), $3.24 (+$0.01), and $3.72 (+$0.01), on 1Q results and guidance."
"While PAY is better positioned now than a year ago, acquisitions have turned it from a simpler organic growth story into a more complicated creature. PAY benefits from secular trends, but is now more opaque given integration costs/risks, one-time items, and additional debt..."
For an analyst ratings summary and ratings history on VeriFone click here. For more ratings news on VeriFone click here.
Shares of VeriFone closed at $46.55 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amazon.com (AMZN) PT Raised to $215 at UBS
- Bristol-Myers Squibb Co. (BMY) PT Lowered to $64 at Truist Securities
- Keefe, Bruyette & Woods Upgrades Trustmark (TRMK) to Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
